Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Caresyntax

Health Tech & Medtech · Boston, United States · Founded 2013 Colt

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation
$500M–1B
Latest valuation · 2026
Unlock exact value
Revenue
$10–50M
Latest reported FY
Unlock exact value
Headcount
100–500
Current team size
Unlock exact value

Investors

21 investors on Caresyntax's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 1 investor entered at this stage
Plug and Play
Series B+ 20 investors entered at this stage
ProAssurance
Mitsubishi
PFM Health Sciences
Pictet
Whiz Partners
IPF Partners
Rezayat Investments
Symbiotic Capital
Aescuvest
Surgical.AI
Optum Ventures
BlackRock
MTIP
Arno Capital
Vesalius Biocapital Partners
Intel Capital
Lauxera Capital Partners
Norgine Ventures
Relyens
Harmonix

Global footprint

Where Caresyntax has talent and traffic

AI talent share
3.5% of workforce is AI talent
(5 of 142 staff)
Core AI21.41%
Other AI32.11%
Non-AI workforce13796.48%
Web traffic by country
5.8K monthly visits
across markets
🇺🇸 United States75.9%
🇬🇧 United Kingdom12.1%
🇮🇳 India10.3%
🇦🇺 Australia1.7%
🇨🇦 Canada1.7%
Top 5 markets shown

See Caresyntax on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo